Related Experiment Video
Updated: May 21, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Infective endocarditis in intravenous drug abusers: an update
C Sousa1, C Botelho, D Rodrigues
1IBB-Institute for Biotechnology and Bioengineering, Centre for Biological Engineering, Universidade do Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
Polymicrobial endocarditis, often seen in intravenous drug abusers, commonly affects the right heart side and tricuspid valve. Understanding patient history and common organism combinations is crucial for effective treatment of this serious infection.
Area of Science:
- Cardiology
- Infectious Diseases
- Microbiology
Background:
- Infective endocarditis (IE) remains a significant cause of hospitalization, associated with high morbidity and mortality.
- Polymicrobial endocarditis (PE) predominantly affects intravenous drug abusers, often involving the right side of the heart and tricuspid valve.
Purpose of the Study:
- To review the literature on polymicrobial endocarditis, focusing on its epidemiology, common causative organisms, and risk factors.
- To highlight the importance of patient history in tailoring therapy for PE.
Main Methods:
- Literature review of studies on infective endocarditis and polymicrobial endocarditis.
- Analysis of reported cases and risk factors associated with PE.
Main Results:
- Polymicrobial endocarditis is strongly associated with intravenous drug abuse.
- Commonly implicated organisms include Staphylococcus aureus, Streptococcus pneumoniae, Pseudomonas aeruginosa, and Candida species.
- Tricuspid valve involvement is frequent in this patient population.
Conclusions:
- Knowledge of patient history, particularly drug use, is critical for effective PE therapy adjustment.
- Further research, including prospective studies, is needed to better understand PE epidemiology and risk factors, despite challenges due to rarity.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

